Latest Period
Q1 2026
Security Snapshot
Acurx Pharmaceuticals, Inc. - Common Stock, Par Value $0.01 per share (ACXP) Institutional Ownership
CUSIP: 00510M203
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
22
Shares (Excl. Options)
183,186
Price
$3.71
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, Par Value $0.01 per share
- Symbol
- ACXP on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 183,186
- Total 13F value
- $679,141
- Portfolio coverage rank
- 0%
- Share change
- +20,553
- Value change
- +$147,251
- Number of holders
- 22
- Shares outstanding
- 12,886,256
- SEC-reported price per share
- $2.05
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ACXP - Acurx Pharmaceuticals, Inc. - Common Stock, Par Value $0.01 per share is tracked under CUSIP 00510M203.
- 22 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 18 to 22 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $345,155 to $679,141.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 22 institutions filings for Q1 2026.
Security key
00510M203
Latest holder period
Q1 2026
13F holders
22
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
ACXP full holder history
Acurx Pharmaceuticals, Inc. SEC filings
Acurx Pharmaceuticals, Inc. company facts
Acurx Pharmaceuticals, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00510M203:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
ACXP
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 10% | 1,287,337 | Armistice Capital, LLC | 30 Jun 2025 |
As of 31 Mar 2026, 22 institutional investors reported holding 183,186 shares of Acurx Pharmaceuticals, Inc. - Common Stock, Par Value $0.01 per share (ACXP). This represents 1.4% of the company’s total 12,886,256 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Latest
Q1 2026
Rows shown
1-4 of 4